Brinker Capital Investments’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54M Sell
55,105
-3,192
-5% -$89.8K 0.01% 936
2026
Q1
$1.66M Sell
58,297
-1,841
-3% -$62.8K 0.01% 847
2025
Q4
$2.38M Sell
60,138
-1,340
-2% -$49.1K 0.02% 757
2025
Q3
$2.17M Sell
61,478
-2,123
-3% -$73.1K 0.02% 793
2025
Q2
$2.08M Sell
63,601
-105
-0.2% -$3.41K 0.02% 765
2025
Q1
$2.06M Buy
63,706
+19,122
+43% +$710K 0.02% 689
2024
Q4
$1.36M Buy
44,584
+3,963
+10% +$127K 0.01% 889
2024
Q3
$1.14M Sell
40,621
-40,829
-50% -$1.01M 0.01% 985
2024
Q2
$1.85M Buy
81,450
+13,329
+20% +$308K 0.02% 675
2024
Q1
$2.07M Buy
68,121
+14,360
+27% +$481K 0.02% 646
2023
Q4
$1.88M Sell
53,761
-17,393
-24% -$647K 0.02% 660
2023
Q3
$3.12M Sell
71,154
-3,808
-5% -$186K 0.04% 421
2023
Q2
$3.7M Sell
74,962
-4,807
-6% -$222K 0.04% 408
2023
Q1
$3.31M Buy
79,769
+13,534
+20% +$562K 0.04% 391
2022
Q4
$2.94M Sell
66,235
-5,843
-8% -$244K 0.06% 340
2022
Q3
$2.82M Buy
72,078
+14,110
+24% +$646K 0.06% 323
2022
Q2
$2.37M Sell
57,968
-31,865
-35% -$1.51M 0.04% 405
2022
Q1
$5.9M Sell
89,833
-3,222
-3% -$209K 0.09% 217
2021
Q4
$6.47M Sell
93,055
-8,230
-8% -$598K 0.09% 211
2021
Q3
$8.04M Hold
101,285
– – 0.13% 161
2021
Q2
$8.04M Buy
101,285
+78,004
+335% +$5.67M 0.11% 201
2021
Q1
$1.52M Sell
23,281
-19,847
-46% -$1.22M 0.02% 580
2020
Q4
$2.4M Buy
43,128
+31,100
+259% +$1.34M 0.04% 509
2020
Q3
$480K Buy
+12,028
New +$510K 0.01% 916

Other funds holding ATRC

Brinker Capital Investments's ATRC Position: Q2 2026 in Review

Brinker Capital Investments reduced its AtriCure (ATRC) stake by 5.5% in Q2 2026, selling an estimated $89.8K and leaving 55,105 shares worth $1.54M. The position accounts for 0.01% of the portfolio, ranked #936.

Brinker Capital Investments first reported a position in ATRC in Q3 2020 and has held it in 24 quarters since. The position peaked at $8.04M in Q3 2021. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Brinker Capital Investments held 55,105 shares of AtriCure worth $1.54M as of Q2 2026.
  • Brinker Capital Investments sold 3,192 AtriCure shares in Q2 2026, an estimated $89.8K.
  • AtriCure made up 0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #936 holding.
  • Brinker Capital Investments first reported a position in AtriCure in Q3 2020 and has held it in 24 quarters since.
  • Brinker Capital Investments's AtriCure position peaked at $8.04M in Q3 2021.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.